Ana Graf
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Cholinesterase and Neurodegenerative Diseases, Computational Drug Discovery Methods, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup(2024)1,822 cited
- → Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study(2012)301 cited
- → The BACE ‐1 inhibitor CNP 520 for prevention trials in Alzheimer's disease(2018)169 cited
- → Revised criteria for the diagnosis and staging of Alzheimer’s disease(2024)140 cited
- → Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease(2015)140 cited
- → AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding study(2013)136 cited
- → Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study(2016)134 cited
- → Measuring cognition and function in the preclinical stage of Alzheimer's disease(2018)126 cited
- → The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease(2019)116 cited
- → Active immunotherapy options for Alzheimer’s disease(2014)95 cited